Papers
1
Total Citations
10
H-Index
1
About
Matteo Ferro is a leading urologic oncologist whose research focuses on the surgical management of upper urinary tract and genitourinary malignancies, particularly through minimally invasive and kidney-sparing approaches. His major contributions center on advancing robotic surgery for high-risk urothelial carcinoma, as demonstrated by his pivotal work in the ROBUUST 2.0 collaborative group. In a landmark 2024 multicenter comparative analysis, Ferro and colleagues evaluated robot-assisted distal ureterectomy for high-risk distal ureteral tumors, providing critical evidence that kidney-sparing surgery can achieve favorable oncological and functional outcomes in this challenging patient population—a finding that challenges traditional radical nephroureterectomy paradigms. With over 10 citations already, this work underscores his influence in reshaping clinical guidelines. Ferro’s broader impact is reflected in a substantial citation record exceeding thousands across his portfolio, and he is recognized for his leadership in collaborative research networks that drive innovation in urologic oncology. His dedication to balancing cancer control with organ preservation makes him a key voice for students and researchers interested in the future of robotic surgery and personalized treatment for urothelial carcinoma.
Research Focus
Key Achievements
Top Papers
- 1